From November 28 to 30, 2025, the Annual Academic Conference of the Chinese Society of Sports Medicine (CSSM 2025), hosted by the Chinese Medical Association and its Sports Medicine Branch, and organized by the Shaanxi Medical Association and Xi’an Red Cross Hospital, was successfully held in the historic city of Xi’an. Focusing on cutting-edge advances and clinical practice in sports medicine, the conference brought together leading experts and scholars to explore new opportunities for growth and collaboration.
As a representative enterprise in China’s sports medicine industry, Delta Medical showcased its full product portfolio at the event, engaging with peers in a forward-looking dialogue on innovation, integration, and the future of the field.
At this year’s conference, Delta Medical systematically presented its complete solution portfolios for the newly developed hip and ankle product lines, further enriching its comprehensive offerings in sports medicine. The BioCore™ series—including HA-PEEK, CF-PEEK, and bioabsorbable anchors and interference screws—also drew great attention.
Among them, the newly launched BioCore™ anchor became a highlight at the booth. Designed to provide strong initial fixation and gradually degrade as tissue heals, the anchor embodies a transition from mechanical stability to biological restoration.
In rehabilitation solutions, the anti-gravity treadmill—equipped with differential air pressure technology—enables precise body-weight support and dynamic load adjustment tailored to different recovery stages, effectively reducing joint stress during exercise. Combined with an intelligent management system that monitors and analyzes gait data in real time, it delivers personalized rehabilitation plans for patients.
Throughout the conference, numerous experts and scholars visited the Delta Medical booth. They not only affirmed the clinical value of Delta’s existing products but also shared valuable insights on industry trends and product innovation, injecting fresh momentum into Delta’s future development.
Coinciding with Delta Medical’s “100,000 V-Lock™ All-Suture Anchor Milestone Celebration,” the recognition and support from peers are especially meaningful. Looking ahead, we will continue to build on professionalism, uphold quality as our core, and relentlessly pursue technological advancement and product excellence.
This conference served not only as a platform to showcase Delta’s technological achievements but also as an opportunity to strengthen collaboration and align visions with industry partners. Delta Medical will remain committed to its mission—“Restore Motion to Life”—continuing to bring innovative energy to the field of sports medicine and contributing to the advancement of public health.